Compound 31
Identifiers
- Canonical SMILES: CC(=O)N1CCN(CC1)c1cc(ccn1)-c1ccc(Sc2ccc3OCCOc3c2)c(c1)C(F)(F)F 
- IUPAC name: 1-[4-[4-[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-3-(trifluoromethyl)phenyl]pyridin-2-yl]piperazin-1-yl]ethanone 
- InChi: InChI=1S/C26H24F3N3O3S/c1-17(33)31-8-10-32(11-9-31)25-15-19(6-7-30-25)18-2-5-24(21(14-18)26(27,28)29)36-20-3-4-22-23(16-20)35-13-12-34-22/h2-7,14-16H,8-13H2,1H3 
- InChiKey: BVXBVMYTIQBMPV-UHFFFAOYSA-N 
External links
|  21906767 |  CHEMBL182384 |  10657276 | 
External search
|   |   |   |   |   | 
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests | 
|---|---|---|---|
| 0 | 1 | 0 | 0 | 
Targets
| PPI family | Best activity | Diseases | MMoA | 
|---|---|---|---|
| LFA / ICAM | 6.88 | immune system disease | Inhibition | 
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 515.15 g/mol | |||
| HBA | 6 | |||
| HBD | 0 | |||
| HBA + HBD | 6 | |||
| AlogP | 4.76 | |||
| TPSA | 54.90 | |||
| RB | 5 | 
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests | 
|---|---|---|---|---|
| 1 | 0 | 1 | 0 | 0 | 
| Ta | Structure | Name | Drugbank ID | 
|---|---|---|---|
| 0.6353 | 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine | DB02177 | |
| 0.5220 | Bitopertin | DB12426 | |
| 0.5026 | Netupitant | DB09048 | |
| 0.4865 | ORM-13070 C-11 | DB15324 | |
| 0.4847 | Lecozotan | DB12540 | |
| 0.4809 | 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol | DB07969 | |
| 0.4641 | Fosnetupitant | DB14019 | |
| 0.4340 | Mepyramine | DB06691 | |
| 0.4326 | 1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE | DB08543 | |
| 0.4163 | Blonanserin | DB09223 | |
| 0.4154 | Atevirdine | DB12264 | |
| 0.4089 | E-6005 | DB12776 | |
| 0.4064 | 4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine | DB03916 | |
| 0.4030 | TT-301 | DB12899 | |
| 0.3980 | Doxazosin | DB00590 | 
 
                        